RT Journal Article
SR Electronic
T1 Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007288
DO 10.1136/jitc-2023-007288
VO 11
IS 10
A1 Hall, MacLean S.
A1 Teer, Jamie K.
A1 Yu, Xiaoqing
A1 Branthoover, Holly
A1 Snedal, Sebastian
A1 Rodriguez-Valentin, Madeline
A1 Nagle, Luz
A1 Scott, Ellen
A1 Schachner, Ben
A1 Innamarato, Patrick
A1 Hall, Amy M.
A1 Blauvelt, Jamie
A1 Rich, Carolyn J.
A1 Richards, Allison D.
A1 Ceccarelli, Jake
A1 Langer, TJ
A1 Yoder, Sean J.
A1 Beatty, Matthew S.
A1 Cox, Cheryl A.
A1 Messina, Jane L.
A1 Abate-Daga, Daniel
A1 Mule, James J.
A1 Mullinax, John E.
A1 Sarnaik, Amod A.
A1 Pilon-Thomas, Shari
YR 2023
UL http://jitc.bmj.com/content/11/10/e007288.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.